IBDEI0JF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9131,1,5,0)
 ;;=5^354.0
 ;;^UTILITY(U,$J,358.3,9131,2)
 ;;=^19944
 ;;^UTILITY(U,$J,358.3,9132,0)
 ;;=357.2^^38^516^2
 ;;^UTILITY(U,$J,358.3,9132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9132,1,4,0)
 ;;=4^DIABETIC POLYNEUROPATHY
 ;;^UTILITY(U,$J,358.3,9132,1,5,0)
 ;;=5^357.2
 ;;^UTILITY(U,$J,358.3,9132,2)
 ;;=^96321
 ;;^UTILITY(U,$J,358.3,9133,0)
 ;;=355.8^^38^516^4
 ;;^UTILITY(U,$J,358.3,9133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9133,1,4,0)
 ;;=4^MONONEURITIS LOWER LIMB
 ;;^UTILITY(U,$J,358.3,9133,1,5,0)
 ;;=5^355.8
 ;;^UTILITY(U,$J,358.3,9133,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,9134,0)
 ;;=354.9^^38^516^6
 ;;^UTILITY(U,$J,358.3,9134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9134,1,4,0)
 ;;=4^MONONEURITIS UPPER LIMB
 ;;^UTILITY(U,$J,358.3,9134,1,5,0)
 ;;=5^354.9
 ;;^UTILITY(U,$J,358.3,9134,2)
 ;;=^268509
 ;;^UTILITY(U,$J,358.3,9135,0)
 ;;=355.9^^38^516^5
 ;;^UTILITY(U,$J,358.3,9135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9135,1,4,0)
 ;;=4^MONONEURITIS NOS
 ;;^UTILITY(U,$J,358.3,9135,1,5,0)
 ;;=5^355.9
 ;;^UTILITY(U,$J,358.3,9135,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,9136,0)
 ;;=785.4^^38^517^1
 ;;^UTILITY(U,$J,358.3,9136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9136,1,4,0)
 ;;=4^GANGRENE
 ;;^UTILITY(U,$J,358.3,9136,1,5,0)
 ;;=5^785.4
 ;;^UTILITY(U,$J,358.3,9136,2)
 ;;=^49194
 ;;^UTILITY(U,$J,358.3,9137,0)
 ;;=337.1^^38^517^3
 ;;^UTILITY(U,$J,358.3,9137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9137,1,4,0)
 ;;=4^PERIPHERAL AUTO NEUROPATHY SEC
 ;;^UTILITY(U,$J,358.3,9137,1,5,0)
 ;;=5^337.1
 ;;^UTILITY(U,$J,358.3,9137,2)
 ;;=^268435
 ;;^UTILITY(U,$J,358.3,9138,0)
 ;;=443.81^^38^517^2
 ;;^UTILITY(U,$J,358.3,9138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9138,1,4,0)
 ;;=4^PERIPHERAL ANGIOPATHY SEC
 ;;^UTILITY(U,$J,358.3,9138,1,5,0)
 ;;=5^443.81
 ;;^UTILITY(U,$J,358.3,9138,2)
 ;;=^92164
 ;;^UTILITY(U,$J,358.3,9139,0)
 ;;=491.21^^38^518^1
 ;;^UTILITY(U,$J,358.3,9139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9139,1,4,0)
 ;;=4^OBS CHR BRONCHITIS EXACERB
 ;;^UTILITY(U,$J,358.3,9139,1,5,0)
 ;;=5^491.21
 ;;^UTILITY(U,$J,358.3,9139,2)
 ;;=^330084
 ;;^UTILITY(U,$J,358.3,9140,0)
 ;;=585.1^^38^519^4
 ;;^UTILITY(U,$J,358.3,9140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9140,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE I
 ;;^UTILITY(U,$J,358.3,9140,1,5,0)
 ;;=5^585.1
 ;;^UTILITY(U,$J,358.3,9140,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,9141,0)
 ;;=585.2^^38^519^5
 ;;^UTILITY(U,$J,358.3,9141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9141,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE II
 ;;^UTILITY(U,$J,358.3,9141,1,5,0)
 ;;=5^585.2
 ;;^UTILITY(U,$J,358.3,9141,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,9142,0)
 ;;=585.3^^38^519^6
 ;;^UTILITY(U,$J,358.3,9142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9142,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE III
 ;;^UTILITY(U,$J,358.3,9142,1,5,0)
 ;;=5^585.3
 ;;^UTILITY(U,$J,358.3,9142,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,9143,0)
 ;;=585.4^^38^519^7
 ;;^UTILITY(U,$J,358.3,9143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9143,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE IV
 ;;^UTILITY(U,$J,358.3,9143,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,9143,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,9144,0)
 ;;=585.5^^38^519^8
 ;;^UTILITY(U,$J,358.3,9144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9144,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE V
 ;;^UTILITY(U,$J,358.3,9144,1,5,0)
 ;;=5^585.5
 ;;^UTILITY(U,$J,358.3,9144,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,9145,0)
 ;;=585.6^^38^519^9
 ;;^UTILITY(U,$J,358.3,9145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9145,1,4,0)
 ;;=4^END STAGE RENAL DISEASE
 ;;
 ;;$END ROU IBDEI0JF
